(Q37775637)

23 August 2017

1 reference

title

Therapeutic targeting of miRNAs in neuroblastoma (English)

1 reference

23 August 2017

1 reference

23 August 2017

Raymond L Stallings

1 reference

23 August 2017

Niamh H Foley

series ordinal

1 reference

23 August 2017

Patrick G Buckley

series ordinal

1 reference

23 August 2017

Isabella Bray

series ordinal

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

Expert Opinion on Therapeutic Targets

23 August 2017

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

951-962

1 reference

MicroRNAs: small RNAs with a big role in gene regulation

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

miR-148 targets human DNMT3b protein coding region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

The impact of microRNAs on protein output

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MicroRNA-373 induces expression of genes with complementary promoter sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Switching from repression to activation: microRNAs can up-regulate translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Regulation of apoptosis by alternative pre-mRNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

The complexities of microRNA regulation: mirandering around the rules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Microarray analysis of microRNA expression in the developing mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

miRNAs in cancer: approaches, aetiology, diagnostics and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MicroRNAs and cancer: what we know and what we still have to learn

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MicroRNAs and cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

The guardian's little helper: microRNAs in the p53 tumor suppressor network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

The role of microRNAs in cancer: no small matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Neuroblastoma: biological insights into a clinical enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

New therapeutic targets for the treatment of high-risk neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Chromosome 1p and 11q deletions and outcome in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Overall genomic pattern is a predictor of outcome in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Are chromosomal imbalances important in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MYCN regulates oncogenic MicroRNAs in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

New miRNAs cloned from neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

The MYCN oncogene is a direct target of miR-34a

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

A microRNA component of the p53 tumour suppressor network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Transcriptional activation of miR-34a contributes to p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

A microRNA polycistron as a potential human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Retinoid therapy of childhood cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Identification of miRNAs that are associated with tumor metastasis in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Targeting microRNAs with small molecules: from dream to reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Therapeutic microRNA strategies in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.510136

10.1517/14728222.2010.510136

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference